Related Experiment Video
Updated: Jun 17, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53
Su Wang1, Shufen Zhong2, Ying Huang2
1Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Introduction:
MDM2 is known as the primary negative regulator of p53, and MDM2 promotes lung cancer fibrosis and lung injury through p53-dependent and p53-independent pathways. However, the mechanism by which MDM2 influences the pathogenesis of asthma is unknown. In this study, we investigated the function of MDM2 in lung epithelial cells in type 2 lung inflammation.
Methods:
We used type II alveolar epithelial cell-specific heterozygous knockout of Mdm2 mice to validate its function. Then papain-induced asthma model was established, and changes in inflammation were observed by measuring immunohistochemistry and flow cytometry analysis.
Results:
In this study, we knockdown the mouse Mdm2 gene in type 2 alveolar epithelial cells. We demonstrated that heterozygous Mdm2 gene-deleted mice were highly susceptible to protease allergen papain-induced pulmonary inflammation characterized by increased ILC2 numbers, IL-5 and IL-13 cytokine levels, and lung pathology. A mechanistic study showed that following the decreased expression of Mdm2 in lung epithelial cells and A549 cell line, p53 was overactivated, and the expression of its downstream genes p21, Puma, and Noxa was elevated, which resulted in apoptosis. After Mdm2 knockdown, the mRNA expression of inflammation-related gene IL-25, HMGB1, and TNF-α were increased, which further amplified the downstream ILC2 response and lung inflammation.
Conclusion:
These results indicate that Mdm2 maintains the homeostasis of lung epithelial cells by targeting P53 and regulates the function of lung epithelial cells under type 2 lung inflammation.
Insights
MDM2 regulates lung epithelial cell homeostasis by targeting p53. Loss of MDM2 in lung cells exacerbates allergic asthma by increasing inflammation and cell apoptosis.
Area of Science:
- Immunology
- Molecular Biology
- Pulmonology
Background:
- MDM2 is a key negative regulator of p53.
- MDM2 influences lung injury and fibrosis via p53-dependent and independent pathways.
- The role of MDM2 in asthma pathogenesis remains unclear.
Purpose of the Study:
- To investigate the function of MDM2 in lung epithelial cells during type 2 lung inflammation.
- To elucidate the mechanism of MDM2's influence on asthma.
Main Methods:
- Utilized type II alveolar epithelial cell-specific heterozygous knockout of Mdm2 mice.
- Established a papain-induced asthma model.
- Analyzed inflammation through immunohistochemistry and flow cytometry.
Main Results:
- Mdm2 gene knockdown in type 2 alveolar epithelial cells led to increased susceptibility to papain-induced pulmonary inflammation.
- Observed elevated ILC2 numbers, IL-5 and IL-13 cytokine levels, and lung pathology in Mdm2-deficient mice.
- Decreased Mdm2 expression resulted in p53 overactivation, apoptosis, and increased expression of inflammation-related genes (IL-25, HMGB1, TNF-α), amplifying ILC2 response.
Conclusions:
- MDM2 is crucial for maintaining lung epithelial cell homeostasis by regulating p53.
- MDM2 controls lung epithelial cell function in the context of type 2 lung inflammation.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

